ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,840Medicare Part D Prescriptions Filled, Including Refills

Rank: 201 out of 617

$333K Total Retail Price of All Prescriptions

Rank: 204 out of 617

472 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 472 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 472 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,382 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 377 374 1 1
OMEPRAZOLE 278 259 2 3
FUROSEMIDE 228 221 3 4
POTASSIUM CHLORIDE 202 202 4 10
LISINOPRIL 162 150 5 5
HYDROCHLOROTHIAZIDE 149 145 6 13
SIMVASTATIN 142 141 7 2
HYDROCODONE-ACETAMINOPHEN 137 115 S3 8 8
METFORMIN HCL 129 121 9 9
WARFARIN SODIUM 126 120 10 7
TRAMADOL HCL 116 104 11 15
DIOVAN 114 111 12 41
DIGOXIN 109 109 13 48
EXFORGE 105 105 14 193
ZOLPIDEM TARTRATE 104 73 15 23
CITALOPRAM HBR 101 101 16 18
NAMENDA 94 94 17 35
LOSARTAN POTASSIUM 88 81 18 22
METOPROLOL TARTRATE 85 78 19 11
RISPERIDONE 83 83 20 71
CEPHALEXIN 79 76 21 68
GABAPENTIN 76 68 22 16
SERTRALINE HCL 75 75 23 20
CARVEDILOL 68 68 24 19
TRIAMTERENE-HCTZ 68 66 24 47
TAMSULOSIN HCL 66 66 26 26
DONEPEZIL HCL 66 66 26 30
ZETIA 64 64 28 77
FLUTICASONE PROPIONATE 60 57 29 36
PROBENECID 58 58 30 294
AVODART 57 57 31 144
IBUPROFEN 56 56 32 140
AMLODIPINE BESYLATE 55 42 33 6
ATENOLOL 54 54 34 17
METOPROLOL SUCCINATE 53 45 35 12
ATORVASTATIN CALCIUM 53 49 35 14
ESCITALOPRAM OXALATE 51 49 37 65
ISOSORBIDE MONONITRATE ER 50 50 38 52
NAPROXEN 50 46 38 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.